CIK: 1594274 - Address: C/o Syndax Pharmaceuticals, Inc., 35 Gatehouse Drive, Building D, Floor 3, Waltham, MA 02451
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
2/17/23 18:09
2/15/23
SNDXSyndax Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsOrdentlich PeterMAOChief ScS.d-64625.840-25-1000D
2/3/23 16:59
2/1/23
SNDXSyndax Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsOrdentlich PeterMAOChief ScS.d-228.4300-1000D
12/2/22 17:01
12/1/22
SNDXSyndax Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsOrdentlich PeterMAOChief ScS.dm-62625.040-25-990D
8/26/22 16:14
8/24/22
SNDXSyndax Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsOrdentlich PeterMAOChief ScS.d-62625.040-25-990D
2/3/22 17:32
2/1/22
SNDXSyndax Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsOrdentlich PeterMAOChief ScS.d-2416.650-1-1000D
11/25/20 16:38
11/23/20
SNDXSyndax Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsOrdentlich PeterMAOChief ScS.d-69423.160-30-1000D
4/3/18 16:42
4/3/18
SNDXSyndax Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsOrdentlich PeterMAOChief ScS.d-11315.000-8-1000D
5/19/17 11:27
5/17/17
SNDXSyndax Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsOrdentlich PeterMAOChief ScS.d-7515.001-5-1000D-35-16-15-37-15113

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact